These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 20868309
1. Hyperuricaemia and accelerated reduction in renal function. Kuo CF, Luo SF, See LC, Ko YS, Chen YM, Hwang JS, Chou IJ, Chang HC, Chen HW, Yu KH. Scand J Rheumatol; 2011 Mar; 40(2):116-21. PubMed ID: 20868309 [Abstract] [Full Text] [Related]
2. Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study. Sturm G, Kollerits B, Neyer U, Ritz E, Kronenberg F, MMKD Study Group. Exp Gerontol; 2008 Apr; 43(4):347-52. PubMed ID: 18294794 [Abstract] [Full Text] [Related]
3. Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study. Imai E, Horio M, Yamagata K, Iseki K, Hara S, Ura N, Kiyohara Y, Makino H, Hishida A, Matsuo S. Hypertens Res; 2008 Mar; 31(3):433-41. PubMed ID: 18497462 [Abstract] [Full Text] [Related]
4. High levels of uric acid correlate with decline of glomerular filtration rate in chronic kidney disease. Satirapoj B, Supasyndh O, Nata N, Phulsuksombuti D, Utennam D, Kanjanakul I, Choovichian P, Duangurai K. J Med Assoc Thai; 2010 Nov; 93 Suppl 6():S65-70. PubMed ID: 21280518 [Abstract] [Full Text] [Related]
5. Serum uric acid is independently associated with metabolic syndrome in subjects with and without a low estimated glomerular filtration rate. See LC, Kuo CF, Chuang FH, Li HY, Chen YM, Chen HW, Yu KH. J Rheumatol; 2009 Aug; 36(8):1691-8. PubMed ID: 19531754 [Abstract] [Full Text] [Related]
6. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Siu YP, Leung KT, Tong MK, Kwan TH. Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385 [Abstract] [Full Text] [Related]
7. Use of the CKD-EPI equation for estimation of GFR in an Australian cohort. Jones GR. Pathology; 2010 Jan; 42(5):487-8. PubMed ID: 20632832 [No Abstract] [Full Text] [Related]
8. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. Fliser D, Kollerits B, Neyer U, Ankerst DP, Lhotta K, Lingenhel A, Ritz E, Kronenberg F, MMKD Study Group, Kuen E, König P, Kraatz G, Mann JF, Müller GA, Köhler H, Riegler P. J Am Soc Nephrol; 2007 Sep; 18(9):2600-8. PubMed ID: 17656479 [Abstract] [Full Text] [Related]
9. Hyperuricaemia is associated with renal damage independently of hypertension and intrarenal renin-angiotensin system activation, as well as their circadian rhythms. Ohashi N, Ishigaki S, Isobe S, Tsuji N, Iwakura T, Ono M, Tsuji T, Sakao Y, Kato A, Yasuda H. Nephrology (Carlton); 2015 Nov; 20(11):814-9. PubMed ID: 25968901 [Abstract] [Full Text] [Related]
10. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study. Othman M, Kawar B, El Nahas AM. Nephron Clin Pract; 2009 Nov; 113(1):c16-23. PubMed ID: 19590231 [Abstract] [Full Text] [Related]
11. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors. Ando M, Ohashi K, Akiyama H, Sakamaki H, Morito T, Tsuchiya K, Nitta K. Nephrol Dial Transplant; 2010 Jan; 25(1):278-82. PubMed ID: 19762604 [Abstract] [Full Text] [Related]
12. Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease. Jones C, Roderick P, Harris S, Rogerson M. Nephrol Dial Transplant; 2006 Aug; 21(8):2133-43. PubMed ID: 16644779 [Abstract] [Full Text] [Related]
13. Relationship of uric acid with progression of kidney disease. Chonchol M, Shlipak MG, Katz R, Sarnak MJ, Newman AB, Siscovick DS, Kestenbaum B, Carney JK, Fried LF. Am J Kidney Dis; 2007 Aug; 50(2):239-47. PubMed ID: 17660025 [Abstract] [Full Text] [Related]
14. Uric acid and allograft loss from interstitial fibrosis/tubular atrophy: post hoc analysis from the angiotensin II blockade in chronic allograft nephropathy trial. Hart A, Jackson S, Kasiske BL, Mauer MS, Najafian B, Matas AJ, Spong R, Ibrahim HN. Transplantation; 2014 May 27; 97(10):1066-71. PubMed ID: 24503762 [Abstract] [Full Text] [Related]
15. Are prediction equations for glomerular filtration rate useful for the long-term monitoring of type 2 diabetic patients? Fontseré N, Salinas I, Bonal J, Bayés B, Riba J, Torres F, Rios J, Sanmartí A, Romero R. Nephrol Dial Transplant; 2006 Aug 27; 21(8):2152-8. PubMed ID: 16702203 [Abstract] [Full Text] [Related]
16. Serum cystatin C as an endogenous marker of renal function in patients with chronic kidney disease. Hojs R, Bevc S, Ekart R, Gorenjak M, Puklavec L. Ren Fail; 2008 Aug 27; 30(2):181-6. PubMed ID: 18300118 [Abstract] [Full Text] [Related]
17. Bariatric surgery and progression of chronic kidney disease. Navaneethan SD, Yehnert H. Surg Obes Relat Dis; 2009 Aug 27; 5(6):662-5. PubMed ID: 19359221 [Abstract] [Full Text] [Related]
18. Chronic kidney disease--a common and serious complication after intestinal transplantation. Herlenius G, Fägerlind M, Krantz M, Mölne J, Olausson M, Gäbel M, Friman V, Oltean M, Friman S. Transplantation; 2008 Jul 15; 86(1):108-13. PubMed ID: 18622286 [Abstract] [Full Text] [Related]
19. Association of impaired diurnal blood pressure variation with a subsequent decline in glomerular filtration rate. Davidson MB, Hix JK, Vidt DG, Brotman DJ. Arch Intern Med; 2006 Apr 24; 166(8):846-52. PubMed ID: 16636209 [Abstract] [Full Text] [Related]
20. Moderate-to-severe early-onset hyperuricaemia: a prognostic marker of long-term kidney transplant outcome. Min SI, Yun IJ, Kang JM, Park YJ, Min SK, Ahn C, Kim SJ, Ha J. Nephrol Dial Transplant; 2009 Aug 24; 24(8):2584-90. PubMed ID: 19395726 [Abstract] [Full Text] [Related] Page: [Next] [New Search]